| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/28/1999 | US5958460 Preparation process for a multiparticulate pharmaceutical form with plurality of sequences of controlled release |
| 09/28/1999 | US5958459 Opioid formulations having extended controlled released |
| 09/28/1999 | US5958458 Coated cores containing specific inert carrier such as calcium carbonate, kaolin, and activated carbon with drug on outer surface of the cores; friability of at most 20% and specific flow angle of cores; solid or liquid drug delivery |
| 09/28/1999 | US5958457 Compositions for the delivery of antigens |
| 09/28/1999 | US5958456 Comprising drug, sustained release excipient, and diluent; for oral administration |
| 09/28/1999 | US5958455 Oral solid dosage forms, methods of making same and compositions thereof |
| 09/28/1999 | US5958453 Solid pharmaceutical preparation with improved buccal disintegrability and/or dissolubility |
| 09/28/1999 | US5958452 Sustained release formulation comprising extruded blend of drug, hydrophobic material, hydrophobic fusible carrier divided into unit dose |
| 09/28/1999 | US5958451 Adding gas generating agent to gelatin solution to form gelatin solution containing gas bubbles therein, forming porous capsule from solution containing gas bubbles wherein gas generating agent comprises a weak acid and a weak base |
| 09/28/1999 | US5958450 Method of drug delivery and coated oral dosage forms for use in the method |
| 09/28/1999 | US5958449 Antibiotic formulation and use for bacterial infections |
| 09/28/1999 | US5958448 Siloxane MQ resin vesicles and entrapment |
| 09/28/1999 | US5958447 Patch comprising pressure sensitive adhesive tape including backing layer, adhesive matrix layer having bioactive liquid printed on outer surface in pattern, release liner |
| 09/28/1999 | US5958446 Blend of at least two polymers having differing solubility parameters adjusts the solubility of a drug in the polymeric blend and thereby modulates the delivery of the drug from the system and through the dermis |
| 09/28/1999 | US5958443 Medical uses of in situ formed gels |
| 09/28/1999 | US5958441 Devices comprising chondrogenic protein and methods of inducing endochondral bone formation therewith |
| 09/28/1999 | US5958435 Comprising dispersed water/oil phase where in oil phase contains liposoluble active ingredient; aqueous dispersion medium gelled with polyglyceryl methacrylate and carbomers; sunscreen lotion, moisturizing cream, make-up cream |
| 09/28/1999 | US5958434 Stable gelled water in oil emulsion and its use in the cosmetic, dermatological, veterinary and/or farm produce fields |
| 09/28/1999 | US5958433 Composition comprising water immiscible liquid phase dispersed in external aqueous phase containing lipid vesicles comprising lamellar phase formed of silicone surfactant encapsulating internal phase |
| 09/28/1999 | US5958431 Emulsifying fatty alcohol with at least one from group of glucose, fructose, dextrose, saccharose, galactose, maltose, maltotriose, dextrane, lactose, talose, allose, xylose, levoglucosane, cellusose and starch under acidic conditions |
| 09/28/1999 | US5958430 Thin film composition with biological substance and method of making |
| 09/28/1999 | US5958421 Cosmetic or pharmaceutical composition containing an andiroba extract |
| 09/28/1999 | US5958418 External herbal composition for treating muscle aches and joint pain |
| 09/28/1999 | US5958380 Chewing gum products and the use thereof for remineralizing subsurface dental lesions and for mineralizing exposed dentinal tubules |
| 09/28/1999 | US5958379 Drug is transported to the site of action within a very short time by means of the corresponding body liquid, particularly by means of blood, in order to systemically cause the desired effect |
| 09/28/1999 | US5958378 High dose liposomal aerosol formulations containing cyclosporin A or budesonide |
| 09/28/1999 | US5958377 Methods of delivering gases to gas-depleted environments |
| 09/28/1999 | US5958371 Site specific binding system, nuclear imaging compositions and methods |
| 09/28/1999 | US5958317 Injecting hollow tubular element which is permeable to the active substance to be released with at least two plugs of hardenable material that form discrete hollow chamber; hardening and introducing active substance |
| 09/28/1999 | US5957848 Preparation of further diagnostic agents |
| 09/28/1999 | CA2178021C Tobacco substitute |
| 09/28/1999 | CA2133503C Orally administrable opioid formulations having extended duration of effect |
| 09/28/1999 | CA2076678C Improved chimeric toxins |
| 09/28/1999 | CA2074873C Seamless capsule and process for producing the same |
| 09/28/1999 | CA2017029C Composition |
| 09/26/1999 | CA2264323A1 W/h emulsion, composition comprising such an emulsion and its cosmetic, pharmaceutical or hygienic uses |
| 09/26/1999 | CA2264316A1 O/w emulsion, composition comprising such an emulsion and its use in cosmetic, pharmaceutical and hygiene applications |
| 09/26/1999 | CA2264310A1 O/w emulsion, composition comprising such an emulsion and its use in cosmetic, pharmaceutical and hygiene applications |
| 09/24/1999 | CA2264249A1 Heat-activated skin patch and use of same |
| 09/23/1999 | WO1999047678A2 Interferon alpha plasmids and delivery systems, and methods of making and using the same |
| 09/23/1999 | WO1999047653A1 Suicide gene therapy system for the treatment of brain tumours |
| 09/23/1999 | WO1999047588A1 Production of microparticles |
| 09/23/1999 | WO1999047543A2 Sustained-release composition including amorphous polymer |
| 09/23/1999 | WO1999047532A1 Crystallization of lactitol, crystalline lactitol product and use thereof |
| 09/23/1999 | WO1999047253A1 Fabrication of multilayer-coated particles and hollow shells via electrostatic self-assembly of nanocomposite multilayers on decomposable colloidal templates |
| 09/23/1999 | WO1999047252A2 Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
| 09/23/1999 | WO1999047196A1 Aerosolized active agent delivery |
| 09/23/1999 | WO1999047175A1 Pharmaceutical compositions containing melatonin inclusion complexes |
| 09/23/1999 | WO1999047174A1 Amorphous glasses for stabilising sensitive products |
| 09/23/1999 | WO1999047172A2 Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes |
| 09/23/1999 | WO1999047160A1 Stabilized aqueous peptide solutions |
| 09/23/1999 | WO1999047143A1 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 09/23/1999 | WO1999047130A1 Nanoparticles, method for producing nanoparticles and use of the same |
| 09/23/1999 | WO1999047129A1 Crosslinkable macromers bearing initiator groups |
| 09/23/1999 | WO1999047128A1 Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
| 09/23/1999 | WO1999047127A1 Hydrophilic and hydrophobic polyether polyurethanes and uses therefor |
| 09/23/1999 | WO1999047126A1 Polymer based rapidly dissolving tablets and production processes thereof |
| 09/23/1999 | WO1999047125A1 Controlled release oral tablet having a unitary core |
| 09/23/1999 | WO1999047124A1 Tablets quickly disintegrating in the oral cavity and process for producing the same |
| 09/23/1999 | WO1999047123A1 Pharmaceutical composition containing a statin and aspirin |
| 09/23/1999 | WO1999047122A1 Chewable calcium supplement and method for making it |
| 09/23/1999 | WO1999047121A1 Use of external or internal feminine absorbent articles as support for therapeutic or diagnostic agents |
| 09/23/1999 | WO1999047120A1 Ophthalmic solution comprising glycogen |
| 09/23/1999 | WO1999047073A1 Liquid polymeric compositions for controlled release of bioactive substances |
| 09/23/1999 | WO1999039756A3 Supporting material for medicinal purposes |
| 09/23/1999 | WO1999039740A8 Sensitizing cells to compounds using lipid-mediated gene and compound delivery |
| 09/23/1999 | WO1999039694A3 Compositions containing organic compounds |
| 09/23/1999 | WO1999039693A3 Methods and compositions for detection and diagnosis of infectious diseases |
| 09/23/1999 | WO1999039692A3 Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization |
| 09/23/1999 | WO1999037273A3 Cosmetic and dermatological preparations containing higher electrolyte concentrations |
| 09/23/1999 | WO1999036570A3 Transglutaminase linkage of agents to tissue |
| 09/23/1999 | WO1999036100A3 Polymeric carrier |
| 09/23/1999 | WO1999036030A3 Pharmaceutical composition and method for treating di-hydroxytestosterone dependent conditions |
| 09/23/1999 | WO1999033859A9 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 09/23/1999 | WO1999029304A9 Method for high supercoiled dna content microspheres |
| 09/23/1999 | WO1999027944A9 Prevention and treatment of amyloidogenic disease |
| 09/23/1999 | DE19812152A1 Verwendung von polymerisierten Fettsäurederivaten und Fettalkoholderivaten als Solubilisatoren Use of polymerized fatty acid derivatives and fatty alcohol derivatives as solubilizers |
| 09/23/1999 | DE19811919A1 New copolymer of unsaturated carboxylic acid with ester or amide, used as solubilizer, especially for pharmaceutical or cosmetic preparations |
| 09/23/1999 | DE19811683A1 Ophthalmological use of fluorocarbon with low dissolved oxygen content, e.g. for treating ischemic retinal disease |
| 09/23/1999 | CA2324235A1 Production of microparticles |
| 09/23/1999 | CA2323897A1 Suicide gene therapy system for the treatment of brain tumours |
| 09/23/1999 | CA2323604A1 Interferon alpha plasmids and delivery systems, and methods of making and using the same |
| 09/22/1999 | EP0943680A1 Suicide gene therapy system for the treatment of brain tumours |
| 09/22/1999 | EP0943341A1 Procedure to prepare granulated compositions that contain erythromycin macrolides and procedure to prepare pharmaceutical compositions that contain said macrolides |
| 09/22/1999 | EP0943340A1 Use of polymerised fatty acid and fatty alcohol derivatives as solubilisers |
| 09/22/1999 | EP0943336A1 Peptide-containing pharmaceutical compositions for oral administration |
| 09/22/1999 | EP0943333A1 Medicament for the prevention and/or treatment of breast cancer comprising an inhibitor of estrogen synthesis |
| 09/22/1999 | EP0943331A2 Formulations containing oxaliplatin |
| 09/22/1999 | EP0943330A1 Patch |
| 09/22/1999 | EP0943327A1 Medicinal composition |
| 09/22/1999 | EP0943326A1 Powdery composition for nasal administration |
| 09/22/1999 | EP0943325A1 Process for making homeopathic medicaments |
| 09/22/1999 | EP0943138A1 Flat transdermal medicated self-adhesive patch |
| 09/22/1999 | EP0943005A1 Tissue specific and target rna-specific ribozymes as antimicrobial therapeutics against microbial pathogens |
| 09/22/1999 | EP0942950A1 Co-processed microcrystalline cellulose and calcium carbonate |
| 09/22/1999 | EP0942780A1 Coated particles, methods of making and using |
| 09/22/1999 | EP0942752A1 Anticonvulsant containing composition for treating neuropathic pain |
| 09/22/1999 | EP0942743A1 Topical preparation for introducing peptidaceous pharmacons in living organisms |
| 09/22/1999 | EP0942738A1 Polyethylene glycol esters of polyunsaturated fatty acids |
| 09/22/1999 | EP0942727A1 Transdermal delivery device for azapirone compounds |